International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

Inno8, the first orally administered factor VIII mimetic shows favorable safety, pharmacokinetic, and pharmacodynamic properties in healthy male participants

Authors :

Linda Ingemann¹, Andrea Navarria², Dorthe Gybel Vej Andersen¹, Henrik Mikael Schyllert¹, Mads Kreilgaard¹, Christian Keicher³

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Blood Disorders

Congress oral presentation

Inno8

Are you a healthcare professional?